1. Home
  2. REBN vs EVGN Comparison

REBN vs EVGN Comparison

Compare REBN & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reborn Coffee Inc.

REBN

Reborn Coffee Inc.

N/A

Current Price

$1.39

Market Cap

11.5M

ML Signal

N/A

Logo Evogene Ltd

EVGN

Evogene Ltd

N/A

Current Price

$0.37

Market Cap

11.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
REBN
EVGN
Founded
2015
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Restaurants
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
11.1M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
REBN
EVGN
Price
$1.39
$0.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $3.50
AVG Volume (30 Days)
★ 145.2K
86.9K
Earning Date
04-22-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $8,094,628.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$73.33
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 36.54
N/A
52 Week Low
$0.67
$0.37
52 Week High
$2.95
$1.50

Technical Indicators

Market Signals
Indicator
REBN
EVGN
Relative Strength Index (RSI) 64.16 31.65
Support Level $1.37 $0.37
Resistance Level $2.02 $0.86
Average True Range (ATR) 0.13 0.05
MACD 0.07 -0.01
Stochastic Oscillator 91.14 0.07

Price Performance

Historical Comparison
REBN
EVGN

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is a company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in two reportable segments: Reborn Coffee, which includes both the wholesale and retail sales of coffee, water, and other beverages, and Reborn Logistics, which provides freight forwarding services.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: